YC and Alchemist-backed Segmed Raises $5.2M Funding Round and Launches Medical Real World Imaging Platform

Segmed

PR98824

 

PALO ALTO, Calif., Nov. 16, 2022 /PRNewswire=KYODO JBN/ --

 

Segmed - a cloud-based real-world imaging platform that accelerates innovation

in healthcare by simplifying access to medical data - announced the closing of

a $5.2 million seed+ funding round led by Nina Capital, with participation from

iGan Partners, M3 Inc, Mighty Capital, Expeditions Fund, and Alchemist

Accelerator, bringing total funds raised to more than $10 million. The company

also reported the launch of Segmed Insight.

 

Logo - https://mma.prnewswire.com/media/1346461/Segmed_Logo.jpg

 

Segmed Insight was built with the goal of getting high-quality, real-world

medical imaging datasets in the hands of clinicians, researchers and

developers; particularly those seeking to train or validate their AI algorithms.

 

Medical researchers and AI developers using Segmed Insight can conduct a

search, view studies and reports matching their search criteria, and construct

datasets specific to their parameters. After placing an order, users receive

data in hand within days - a process that took years prior to Segmed.

 

By forging partnerships with healthcare systems, hospitals and imaging clinics

across 1,000 locations on 5 continents, Segmed has done the heavy lifting when

it comes to aggregating diverse medical data.

 

Patient privacy and data stewardship remain paramount at Segmed. The company

maintains strict HIPAA/GDPR compliance, obtained its SOC2 attestation this

year, and only shares fully de-identified data, ensuring that no personal

information is exposed.

 

"The healthcare industry has become increasingly adoptive of artificial

intelligence methods, but a roadblock in the development of unbiased,

high-performing algorithms has been the timely acquisition of diverse,

high-quality data," said Dr. Martin Willemink, CEO and co-founder at Segmed.

"With Insight, our customers can massively cut down on data sourcing time,

which in turn accelerates research and development in the medical field."

 

"Segmed is well positioned to lower the barriers for innovation in medical AI

by bridging the gap between data providers and data consumers," said Sebastian

Anastassiou, Head of Investments at Nina Capital. "This will make it easier to

tackle tough healthcare problems, ultimately improving the quality of patient

care in years to come."

 

"We are excited to be supporting Segmed in their latest raise – we believe that

the company is on a growth trajectory to becoming one of the leading AI data

platforms in the healthcare industry. They have real time access to

machine-readable data with a focus on medical imaging, which is an invaluable

type of data for healthcare. With this round, iGan is looking forward to

working with Martin and the team to drive outbound partnerships and expand key

features of the platform." said Sam Ifergan, Managing Partner at iGan Partners.

 

About Segmed

 

By partnering with global healthcare providers; standardizing and

de-identifying data via a sequence of proprietary algorithms; and allowing

users to build customized datasets, Segmed has become a one-stop-shop for rapid

medical data aggregation. To learn more, visit segmed.ai [

https://c212.net/c/link/?t=0&l=en&o=3708742-1&h=2524390514&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3708742-1%26h%3D214108238%26u%3Dhttps%253A%252F%252Fsegmed.ai%26a%3Dsegmed.ai&a=segmed.ai

] or get started at join.segmed.ai [

https://c212.net/c/link/?t=0&l=en&o=3708742-1&h=795304866&u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D3708742-1%26h%3D772549611%26u%3Dhttp%253A%252F%252Fjoin.segmed.ai%26a%3Djoin.segmed.ai&a=join.segmed.ai

].

 

SOURCE: Segmed

 

CONTACT: rachel@segmed.ai

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中